Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Think Research Corporation V.THNK

Think Research Corporation is a Canada-based company that offers digital health software solutions. It is a provider of cloud-based data, knowledge, and software solutions primarily delivered as software-as-a-service (SaaS) to healthcare delivery systems and the practitioners that they support. Its operations are organized into three lines of business: Software and Data Solutions, Clinical Research, and Clinical Services. Its SaaS solutions help patients find, navigate, and connect to health services across large governments and payer clients, while also ensuring safety for prescribed medications at pharmacies. Through its wholly owned subsidiary, BioPharma Services Inc., the Company provides research data and analysis derived from Phase I clinical trials, bioequivalence studies and bioanalytical services. Its clinics act as a test bed for its software and technology, transforming them with digital solutions that optimize clinical outcomes, streamline workflows, and optimize billing.


TSXV:THNK - Post by User

Post by dt_coreon Jan 23, 2023 11:09am
235 Views
Post# 35239779

Big Client Win in Software Division

Big Client Win in Software DivisionTake this with a grain of salt (possibly a big one). A contact at a large pharma company claims they've signed on a content and learning data provider with a 2 year role out expected throughout their organization. He strongly believes THNK won the mandate. The deal value is expected to be around $20 to $30M rev once fully rolled out (most of that is annual rev with some upfront one time aspects to setup the program).

We know from the last CC that THNK had a number of very large "RFPs" in play that they were hoping to announce in 2023, and so it's possible that the news is true but I'm not convinced given where the share price is currently trading. In other words if it was true you'd expect others to snap up THNK shares and push the price higher in a big way and that hasn't happened. 
<< Previous
Bullboard Posts
Next >>